Question Bank › The company is outgrowing its own explanations

The company is outgrowing its own explanations

The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi

Calls Tested
497
Answered YES
13
Hit Rate
2.6%
rare by design

Pacira BioSciences, Inc. (PCRX) — this company's answers

NO on the Q4 2017 call 2018-02-28 C
The model's full reasoning — Q4 2017 call → NOWe need to determine if management conveys that the reported results for the period (Q4 2017 and full year 2017) do not represent the business the company is actually running today. The question asks: does management repeatedly or substantially indicate that the just-reported numbers describe a company that has already been left behind by what is now actually happening inside the business? We need to look for evidence in the transcript. Management discusses various initiatives, partnerships, J&J collaboration, CMS reimbursement efforts, clinical trials, etc. They also provide guidance for 2018. The key is whether they explicitly say that the reported period's results are stale relative to current operations. For example, they might say that the J&J partnership began late in the period and contributed little, but now it's ramping up. Or they might say that the business is currently running at a higher pace than the reported figures. Let's scan the transcript. Dave Stack says: "Throughout 2017 you could not open a newspaper... The only single administration long acting local analgesic for post-surgical pain, EXPAREL, is uniquely positioned... We are pleased with the significant progress Pacira made during 2017, as we continue to advance our mission... In addition to our own dedicated internal initiatives, we have forged several meaningful partnerships... Our robust partnership with J&J continues to gain traction and helped accelerate EXPAREL daily growth to 10% for the fourth quarter of 2017." That's about the reported period. Later, Charlie Reinhart gives guidance for 2018: "We are guiding to total EXPAREL net product sales of between $300 million and $310 million in 2018. This range aligns with our 2017 year-over-year average daily growth rates recorded during each quarter, ranging from 6% to 10%." So they are guiding to similar growth rates. That doesn't suggest a gap. But then Dave Stack says: "I think the guidance, we believe – well, we hope is conservative. I think as Charlie outlined, we have not done a good job over the last couple of years of making sure that we've met the guidance that we put out there, so we wanted to be appropriately conservative to make sure that we're providing a number to the marketplace that we'll be able to revise upward as the year goes on. But I think Charlie's context was also important.

← Back to the full PCRX analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the company's REPORTED RESULTS FOR THE PERIOD BEING DISCUSSED DO NOT REPRESENT THE BUSINESS THE COMPANY IS ACTUALLY RUNNING TODAY — that is, does management repeatedly or substantially indicate that the just-reported numbers describe a company that has already been left behind by what is now actually happening inside the business? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent posture: the printed period is stale relative to the operating present. Any genuine expression of this counts, and the form varies widely across industries. For example — management explaining that meaningful business, capability, or activity now in motion contributed little or nothing to the reported period because it began late in the period or just after it closed; management noting that the pace, level, or mix of business the company is currently running sits above what the period's figures show; management describing that the period carried the costs of things whose benefits have only just begun; management pointing to what the company has already become — what it can now do, what it now has, what is now committed or underway — and treating the reported numbers as a picture of the company before that; or management consistently answering questions about the future by pointing to what is already in hand, in motion, or being executed rather than to what must still be won. What matters is the DIRECTION OF THE GAP in management's own telling: the business as it stands today is ahead of the business as it appears in the reported period, and management itself is the one drawing attention to that gap, grounded in things that are already real — actual current activity, completed work, committed business, or capabilities already in place — not in hopes, plans, market size, or projections. Answer NO if the call is a conventional results-and-outlook discussion in which the reported period and the described business are essentially the same size — ordinary strength, ordinary guidance, however good. NO if the claimed gap rests mainly on pipeline, bids, negotiations, market opportunity, hoped-for demand, or initiatives with nothing concrete yet occurring. NO if the only "numbers lag the business" language is a single passing remark or boilerplate about investing for the future, with no substance about what has already changed. NO if management is chiefly defending weak results, explaining a slump, or promising a future turnaround from a trough. NO if the recent developments are routine in scale for this company — the normal cadence of wins, openings, or orders it always reports — with no sense that the business has moved to a different level than the print. NO if the gap is asserted only in an analyst's question or model that management does not itself affirm with its own account of current operations. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
PFE Pfizer Inc. Q4 2023 2024-01-30 F
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
NBTX Nanobiotix S.A. Q2 2023 2023-09-27 D
PRPH ProPhase Labs, Inc. Q1 2023 2023-05-11 F
VRE Veris Residential, Inc. Q4 2022 2023-02-22 D
SOL ReneSola Ltd Q3 2022 2022-12-01 C+
FLL Full House Resorts, Inc. Q3 2022 2022-11-07 B
OPK OPKO Health, Inc. Q1 2022 2022-05-09 D
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
OWL Blue Owl Capital Inc. Q2 2021 2021-08-10 B+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C

How the model reasoned

VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.

More from the question bank

Undersized for what it has already been handMid-period crossingsSelf-authored recoveryTheir own money on the lineGrowing out of the old selfGrowing out of the old selfAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.